Hello, how can we help you?

Bacterial endotoxin testing in pharmaceutical products

Bacterial Endotoxin Test in Pharmaceutical Products: The Invisible Protective Shield for Patient Safety

One of the most insidious safety risks in parenteral drugs, infusion solutions, sterile eye preparations and medical devices that come into contact with blood are endotoxins that are not recognizable to the naked eye and through Standard sterilization procedures cannot be completely eliminated. These molecules with lipopolysaccharide structure, which occur in the cell wall of gram-negative bacteria, trigger pyrogenic reactions as soon as they enter the bloodstream, which up to fever, chills, hypotension and can lead to shock. For this reason, the Bacterial Endotoxin Test is an independent quality and safety parameter that must be evaluated regardless of the sterility of the product.

It is possible that a sterile product contains endotoxins. Because although autoclaves or filtration eliminate living microorganisms, they do not destroy the chemical structure of the endotoxins. Therefore, "sterile" and "pyrogen-free" are not synonymous. This distinction illustrates why the endotoxin test is an indispensable component of pharmaceutical quality control.

Why is the endotoxin test so crucial?

The meaning of the endotoxin test can be summarized under four headings:

  • Patient Safety: The presence of endotoxins in a product administered directly into the bloodstream triggers a systemic inflammatory response. The test quantitatively limits this risk.
  • Pharmacopoeia Requirements: The relevant sections of the European pharmacopoeia and the American pharmacopoeia establish binding endotoxin limits and test requirements for parenteral products.
  • Production chain control: Resources, process water, packaging materials and production facilities directly affect the endotoxin load of the final product.
  • Authorized approval: For approval applications, GLP-compliant endotoxin test data is required as an integral part of the quality dossier.

Basic parameters evaluated in endotoxin testing

The following table summarizes the parameters that are crucial for the design and validity of the test:

ParameterDefinitionWhy is he important?Application
Endotoxin Limit (L)The permissible maximum endotoxin amount, calculated from the administration route and the dose of the productForms the basis for the decision on acceptance or rejectionCalculated based on the maximum daily dose and route of administration of the product
Maximum valid dilution (MVD)The highest dilution ratio at which the sample can be testedPlays a crucial role in eliminating matrix interferenceIs determined based on the L-value and the detection sensitivity of the system
Interference testAssess whether the product matrix suppresses the analytical response or notPrevents the risk of false negative or false positive resultsIs confirmed by a positive product control
Positive Product Control (PPC)A control in which a known amount of endotoxin is added to the sampleProves that the test is valid for this batchIs carried out simultaneously in each test
Routine ValidationRepeat interference assessment at certain intervalsEnsures the validity of the test over timeRepeat when changes to the product, raw materials or production site

GLP compliant bacterial endotoxin test with nano test

The endotoxin safety of your pharmaceutical products is guaranteed by a correct test design, complete validation and reporting accepted by the regulatory authorities. Nano-Test is a GLP-accredited solution partner that combines these three components under one roof.

Nano-Test – Performance Description

NANO-TEST offers Bacterial Endotoxin Tests for pharmaceutical products and blood-contacting medical devices. Our analyzes are carried out in full accordance with the relevant sections of the European Pharmaceutical Book and the American Pharmacopoeia.

Benefits of Nano Test in Endotoxin Tests:

  • GLP accreditation: microbiology laboratory with OECD-GLP declaration of conformity.
  • Pharmacopoeia compliance: test protocols and reporting in full compliance with the relevant sections of the pharmacopoeia.
  • Specialist staff: An experienced team in the fields of endotoxin testing, pharmacopoeia validation and pyrogenity assessment.
Note: Endotoxin testing is only part of the safety assessment of parenteral products. It should be considered along with sterility tests, microbiological limit testing, and packaging integrity ratings. Nano-Test accelerates your process by offering all these analyses from a single source.

With its pharmacopeia-compliant infrastructure, its GLP accreditation and product-based test design approach, Nano-Test comprehensively meets the requirements of pharmaceutical manufacturers in the field of endotoxin tests. Collaborate with Nano-Test to document the safety of your products and speed up your approval process.

Leave a Reply

Your email address will not be published.

This field is compulsory.

You may use these <abbr title="HyperText Markup Language">html</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*This field is compulsory.